Wouter N.
- Country
- The Netherlands
- Department
- University Medical Centre Utrecht
Research Overview
- Efficacy and Safety Evaluation of Setrusumab in Osteogenesis Imperfecta: A Randomized Phase 2/3 Study with Dose-Evaluation and Placebo-Controlled Phases
- Phase 3 Evaluation of Setrusumab Versus Bisphosphonates in Pediatric Osteogenesis Imperfecta Types I, III, and IV: A Randomized, Open-label, Active-controlled Study
Data & Insights
Has run more than one trial at 3 of 12 partner sites.
Specializations
Rare Bone Disorders
The investigator specializes in treating osteogenesis imperfecta, also known as brittle bone disease, with a particular focus on pediatric patients. Their research interests center on developing innovative therapeutic approaches for this rare genetic condition.
- Pediatric bone disorders
- Genetic bone diseases
- Fracture prevention strategies
Their work encompasses both traditional and novel treatment modalities for managing bone fragility.
Therapeutic Innovations
The investigator explores comparative effectiveness between conventional bisphosphonate therapy and newer biological treatments. Their research focuses on evaluating therapeutic outcomes in bone strength enhancement and fracture reduction.
- Biological therapies
- Bone-targeting treatments
- Treatment optimization
Their expertise extends to implementing novel therapeutic strategies for improving bone health outcomes.
Clinical Assessment
The investigator specializes in comprehensive evaluation of bone fragility disorders, with particular attention to vertebral and non-vertebral fracture assessment. Their work includes monitoring treatment responses through various clinical parameters.
- Fracture rate evaluation
- Bone strength assessment
- Treatment response monitoring
Their expertise includes advanced methodologies for assessing therapeutic efficacy in bone disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.